HADD SCIENCE TEAM: HADD Location

KOEN Contact us

NEWS›HADD Science signs a clinical partnership on graphene-based early dementia diagnosis

HADD Science signs a clinical partnership on graphene-based early dementia diagnosis

2025.09.10

Graphene Dementia Early Diagnosis Clinical Agreement. Learn more about HADD Science. @haddscience

HADD Science. Graphene-based Dementia Early Diagnosis Clinical Partner Agreement 🤝. MOU Signed with Medical Institution and Deep Tech Company. Kukil Graphene, an SM Group affiliate, has partnered with Chungnam National University Hospital Daejeon Regional Dementia Center to begin clinical validation of graphene-based early dementia diagnosis technology.

chapter 02. MOU Signed with Chungnam National University Hospital 🖋️. HADD Science, along with Kukil Graphene, signed an MOU on the 25th with Professor Oh Eung-seok of Chungnam National University Hospital's Neurology Department (Director of Daejeon Regional Dementia Center),

chapter 02. At the Agreement Ceremony 🙋. HADD Science CEO Heo Chae-jeong, from the bio deep tech company, also attended.. Dementia Diagnosis Technology | Amyloid Beta | Nano New Materials | Spectroscopy

chapter 03. CEO Heo Chae-jeong is a Brain Science Expert 🧠. CEO Heo is a brain science expert who has published numerous papers in international journals on amyloid beta protein research.

chapter 04. Graphene Biosensing Technology 🔬. This agreement aims to combine Kukil Graphene's graphene bio-diagnosis (sensing) technology with Professor Oh's team's clinical experience to validate the efficacy of early dementia diagnosis and accelerate commercialization.

chapter 05. Anticipated Synergy in Medical Field 🤝. Collaboration with a research team that has experience in dementia health policy and a broad network is expected to contribute to synergy in the medical field.

chapter 06. Advancing Graphene Optical Analysis Technology 🧪. Kukil Graphene is currently advancing technology that analyzes the aggregation state of amyloid beta and tau proteins through graphene's optical changes,

chapter 06. Expanding National Dementia Network 🗺️. Through this agreement, we plan to expand the national dementia network and accelerate market entry.

chapter 07. Targeting Mass Production by 2027 🎯. Discussions for collaboration are also underway with two other domestic medical universities besides Chungnam National University Hospital. Clinical validation and prototype development will continue, targeting mass production by 2027.

A Word from CEO Kang Tae-hyun 💬. “Through our partnership with Chungnam National University Hospital, we will accelerate the commercialization of dementia diagnosis technology, expand our R&D scope to include neurodegenerative diseases, and contribute to health in a super-aging society.”. Kang Tae-hyun, CEO of Kukil Graphene

chapter 08. Kukil Graphene Enters Bio-Healthcare 🏢. Established in 2018 as a wholly-owned subsidiary of Kukil Paper, Kukil Graphene is currently strengthening its entry into the bio-healthcare sector, including patent applications for graphene new materials and dementia diagnosis technology.

Related Articles. Original Articles 📰 (1/3). Seoul Shinmun. The Value News. 1conomy News. Seoul Pn

Related Articles. Original Articles 📰 (2/3). Seoul Economic Daily. SR Times. Newsrock. Busan Financial News

Related Articles. Original Articles 📰 (3/3). Global Epic. BUSINESSplus. Small and Medium Business Newspaper. Daily Hankook

Related articles

Seoul Shinmun ↗
The Value News ↗
1conomy News ↗
Seoul Pn ↗
Seoul Economic Daily ↗
SR Times ↗
Newsrock ↗
Busan Financial News ↗
Global epic ↗
BUSINESSplus ↗
Small & Medium Business News ↗
Daily Hankook ↗

← PreviousHADD Science shares ECM-based 3D cell research insights at Ajou University’s 3rd convergence seminar Next →HADD Science selected as a resident company of the Gwanggyo Bio Hub Lab Station

← Back to list

HADD SCIENCE

ADD the values to Human life.

ABOUT

HADD SCIENCE TEAM: HADD Location

PRODUCT

NEWS

News HADD:Library

Tel +82 31 8055 3780

Fax +82 31 375 4782

info@haddscience.com

Head Office Room 505, 5F, Gowoon Advanced Institute of Science and Technology, The University of Suwon, 17 Wauan-gil, Bongdam-eup, Hwaseong-si, Gyeonggi-do, Republic of Korea

Research Collaboration Center Branics Lab, 6F, N Center, Natural Science Campus, Sungkyunkwan University, Suwon, Gyeonggi-do, Republic of Korea

Research Institute Lab Station 8B, 8F, Gyeonggi Bio Center, 147 Gwanggyo-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea

Company: HADD SCIENCECEO: Chaejung HeoBusiness Registration No.: 503-52-46329CEO email: neuroheo@haddscience.com

Copyright © 2026 HADD Science. All rights reserved.

Terms and conditions Privacy policy